CANCER Limitations of therapies exposed

被引：33

作者：

Casanovas, Oriol ^{[1
]}

机构：

[1] Bellvitge Inst Biomed Res, Catalan Inst Oncol, Translat Res Lab, E-08907 Lhospitalet De Llobregat, Spain

来源：

NATURE | 2012年 / 484卷 / 7392期

关键词：

ANTI-ANGIOGENIC THERAPY; ANTIANGIOGENIC THERAPY; TUMOR VASCULATURE; BREAST-CANCER; STEM-CELLS; METASTASIS; RESISTANCE; BEVACIZUMAB; COMBINATION; INHIBITOR;

D O I：

10.1038/484044a

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

[No abstract available]

引用

页码：44 / 46

页数：3

共 18 条

[1] AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients [J].

Batchelor, Tracy T. ;

Sorensen, A. Gregory ;

di Tomaso, Emmanuelle ;

Zhang, Wei-Ting ;

Duda, Dan G. ;

Cohen, Kenneth S. ;

Kozak, Kevin R. ;

Cahill, Daniel P. ;

Chen, Poe-Jou ;

Zhu, Mingwang ;

Ancukiewicz, Marek ;

Mrugala, Maciej M. ;

Plotkin, Scott ;

Drappatz, Jan ;

Louis, David N. ;

Ivy, Percy ;

Scadden, David T. ;

Benner, Thomas ;

Loeffler, Jay S. ;

Wen, Patrick Y. ;

Jain, Rakesh K. .

CANCER CELL, 2007, 11 (01) :83-95

[2] Modes of resistance to anti-angiogenic therapy [J].

Bergers, Gabriele ;

Hanahan, Douglas .

NATURE REVIEWS CANCER, 2008, 8 (08) :592-603

[3] Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance [J].

Boehm, T ;

Folkman, J ;

Browder, T ;

OReilly, MS .

NATURE, 1997, 390 (6658) :404-407

[4] Tumour growth inhibition and anti-metastatic activity of a mutated furin-resistant Semaphorin 3E isoform [J].

Casazza, Andrea ;

Kigel, Boaz ;

Maione, Federica ;

Capparuccia, Lorena ;

Kessler, Ofra ;

Giraudo, Enrico ;

Mazzone, Massimiliano ;

Neufeld, Gera ;

Tamagnone, Luca .

EMBO MOLECULAR MEDICINE, 2012, 4 (03) :234-250

[5] Aldehyde Dehydrogenase 1-Positive Cancer Stem Cells Mediate Metastasis and Poor Clinical Outcome in Inflammatory Breast Cancer [J].

Charafe-Jauffret, Emmanuelle ;

Ginestier, Christophe ;

Iovino, Flora ;

Tarpin, Carole ;

Diebel, Mark ;

Esterni, Benjamin ;

Houvenaeghel, Gilles ;

Extra, Jean-Marc ;

Bertucci, Francois ;

Jacquemier, Jocelyne ;

Xerri, Luc ;

Dontu, Gabriela ;

Stassi, Giorgio ;

Xiao, Yi ;

Barsky, Sanford H. ;

Birnbaum, Daniel ;

Viens, Patrice ;

Wicha, Max S. .

CLINICAL CANCER RESEARCH, 2010, 16 (01) :45-55

[6] Antiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxia [J].

Conley, Sarah J. ;

Gheordunescu, Elizabeth ;

Kakarala, Pramod ;

Newman, Bryan ;

Korkaya, Hasan ;

Heath, Amber N. ;

Clouthier, Shawn G. ;

Wicha, Max S. .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (08) :2784-2789

[7] Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis [J].

Ebos, John M. L. ;

Lee, Christina R. ;

Cruz-Munoz, William ;

Bjarnason, Georg A. ;

Christensen, James G. ;

Kerbel, Robert S. .

CANCER CELL, 2009, 15 (03) :232-239

[8] Anticancer therapies combining antiangiogenic and tumor cell cytotoxic effects reduce the tumor stem-like cell fraction in glioma xenograft tumors [J].

Folkins, Chris ;

Man, Shan ;

Xu, Ping ;

Shaked, Yuval ;

Hicklin, Daniel J. ;

Kerbel, Robert S. .

CANCER RESEARCH, 2007, 67 (08) :3560-3564

[9] Bevacizurnab in combination with fluorouracil and leucovorin: An active regimen for first-line metastatic colorectal cancer [J].

Hurwitz, HI ;

Fehrenbacher, L ;

Hainsworth, JD ;

Heim, W ;

Berlin, J ;

Holmgren, E ;

Hambleton, J ;

Novotny, WF ;

Kabbinavar, F .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (15) :3502-3508

[10] Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy [J].

Jain, RK .

NATURE MEDICINE, 2001, 7 (09) :987-989

← 1 2 →